Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $3 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.
Press Release – New York, NY – November 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as sole book runner in the underwritten public offering of 3,529,412 shares of Cocrystal Pharma, Inc. (NASDAQ: COCP) common stock, at a price of $0.85 per share for gross proceeds of approximately $3.0 million. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio and Avital Perlman, counsel Jeff Cahlon and associate Grant Levine.
- Welcome Marcelle Balcombe Back as a Partner Of SRF. - June 16, 2021
- Sichenzia Ross Ference LLP Adds Former SEC Staff Attorney Ryan Houseal as Corporate & Securities Associate - June 14, 2021
- Sichenzia Ross Ference LLP Represents Red Light Holland Corp. in the $3.2 million Acquisition of Radix Motion Inc. - June 11, 2021